EP3063269A4 - Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells - Google Patents

Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells Download PDF

Info

Publication number: EP3063269A4
Authority: EP; European Patent Office
Prior art keywords: clustering; differentiation; suspension; pluripotent stem; cells
Prior art date: 2013-11-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP14859059.9A

Other languages

German (de)

French (fr)

Other versions

EP3063269A1 (en

Inventor

Benjamin Fryer

Daina LANIAUSKAS

Marcia BLACKMOORE

Haiyun Wang

Kostadinka LILOVA

Shelley Nelson

Elizabeth ROSOCHA

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Biotech Inc

Original Assignee

Janssen Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-11-01

Filing date

2014-06-17

Publication date

2017-07-12

2013-12-30 Priority claimed from US13/998,974 external-priority patent/US10377989B2/en

2014-06-17 Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc

2016-09-07 Publication of EP3063269A1 publication Critical patent/EP3063269A1/en

2017-07-12 Publication of EP3063269A4 publication Critical patent/EP3063269A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/19—Growth and differentiation factors [GDF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Developmental Biology & Embryology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)

EP14859059.9A 2013-11-01 2014-06-17 Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells Withdrawn EP3063269A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361962158P	2013-11-01	2013-11-01
US13/998,974 US10377989B2 (en)	2012-12-31	2013-12-30	Methods for suspension cultures of human pluripotent stem cells
PCT/US2014/042796 WO2015065537A1 (en)	2013-11-01	2014-06-17	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells

Publications (2)

Publication Number	Publication Date
EP3063269A1 EP3063269A1 (en)	2016-09-07
EP3063269A4 true EP3063269A4 (en)	2017-07-12

Family

ID=53004904

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP14857034.4A Withdrawn EP3063268A4 (en)	2013-11-01	2014-05-21	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells
EP14859059.9A Withdrawn EP3063269A4 (en)	2013-11-01	2014-06-17	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EP14857034.4A Withdrawn EP3063268A4 (en)	2013-11-01	2014-05-21	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells

Country Status (12)

Country	Link
EP (2)	EP3063268A4 (en)
JP (2)	JP2016534731A (en)
KR (4)	KR20160079072A (en)
CN (2)	CN105793413A (en)
AU (4)	AU2014342995C1 (en)
BR (1)	BR112016009393A8 (en)
CA (2)	CA2928639A1 (en)
MX (2)	MX2016005657A (en)
PH (2)	PH12016500783A1 (en)
RU (2)	RU2689710C2 (en)
SG (2)	SG11201603045VA (en)
WO (2)	WO2015065524A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2016005657A (en) *	2013-11-01	2017-01-05	Janssen Biotech Inc	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells.
WO2017223233A1 (en) *	2016-06-23	2017-12-28	Tithon Biotech, Inc.	Cells expressing parathyroid hormone 1 receptor and uses thereof
JP7088564B2 (en)	2016-11-10	2022-06-21	ヴィアサイト，インコーポレイテッド	PDX1 pancreatic endoderm cells and methods thereof in a cell delivery device
CA3042562C (en) *	2016-11-16	2023-02-28	Cynata Therapeutics Limited	Pluripotent stem cell assay
US10391156B2 (en)	2017-07-12	2019-08-27	Viacyte, Inc.	University donor cells and related methods
EP4488363A3 (en) *	2017-07-21	2025-03-26	Vertex Pharmaceuticals Incorporated	Re-aggregation of stem cell-derived pancreatic beta cells
JP7000896B2 (en) *	2017-08-23	2022-01-19	王子ホールディングス株式会社	Cell sheet forming member, method for manufacturing cell sheet forming member, and method for manufacturing cell sheet
MX2020007071A (en) *	2018-01-05	2020-11-11	Platelet Biogenesis Inc	Compositions and methods for producing megakaryocytes.
US12104173B2 (en)	2018-01-18	2024-10-01	Agency For Science, Technology And Research	Method for differentiation of human pluripotent stem cell lines in suspension culture
KR102115360B1 (en) *	2018-05-30	2020-05-26	주식회사 바이블리오테카	Adult stem cell culture fluid and a producing method thereof
US10724052B2 (en)	2018-09-07	2020-07-28	Crispr Therapeutics Ag	Universal donor cells
EP3975926A1 (en)	2019-05-31	2022-04-06	W.L. Gore & Associates, Inc.	A biocompatible membrane composite
EP3976237A1 (en)	2019-05-31	2022-04-06	W.L. Gore & Associates Inc.	Cell encapsulation devices with controlled oxygen diffusion distances
AU2020283056B2 (en)	2019-05-31	2023-06-08	Viacyte, Inc.	A biocompatible membrane composite
CA3139591C (en)	2019-05-31	2024-01-16	Timothy M. BRUHN	A biocompatible membrane composite
JP2022547417A (en) *	2019-08-27	2022-11-14	ユナイテッドセラピューティクスコーポレイション	Methods and compositions for culturing alveolar cells
US11118195B2 (en)	2019-09-05	2021-09-14	Crispr Therapeutics Ag	Universal donor cells
AU2020340622A1 (en)	2019-09-05	2022-03-03	Crispr Therapeutics Ag	Universal donor cells
EP4061929A1 (en) *	2019-11-22	2022-09-28	Novo Nordisk A/S	Spin-aggregated neural microspheres and the application thereof
AU2021414405A1 (en)	2020-12-31	2023-08-10	Crispr Therapeutics Ag	Universal donor cells
WO2022203051A1 (en) *	2021-03-25	2022-09-29	株式会社カネカ	Method for producing pluripotent stem cell population
CN116218766A (en) *	2023-04-21	2023-06-06	北京意胜生物科技有限公司	A method for preparing pancreatic precursor cells, culture medium and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014106141A1 (en) *	2012-12-31	2014-07-03	Janssen Biotech, Inc.	Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
WO2015065524A2 (en) *	2013-11-01	2015-05-07	Janssen Biotech, Inc.	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005533480A (en) *	2001-11-09	2005-11-10	アーテセル・サイエンシズ・インコーポレーテツド	Pancreatic endocrine differentiation of adipose tissue-derived stromal cells and use thereof
DK3441459T3 (en) *	2006-08-02	2021-06-07	Technion Res & Dev Foundation	PROCEDURES FOR EXPANSION OF EMBRYONAL STEM CELLS IN A SUSPENSION CULTURE
EP2088190A4 (en) *	2006-11-09	2011-01-05	Japan Government	METHOD FOR THE CULTURE AND PASSAGE OF PRIMATE EMBRYONIC STRAIN CELL, AND METHOD FOR INDUCING DIFFERENTIATION OF EMBRYONIC STEM CELL
US20090053182A1 (en) *	2007-05-25	2009-02-26	Medistem Laboratories, Inc.	Endometrial stem cells and methods of making and using same
WO2009006399A1 (en) *	2007-07-01	2009-01-08	Lifescan	Single pluripotent stem cell culture
JP2011514169A (en) *	2008-03-17	2011-05-06	エージェンシーフォーサイエンス，テクノロジーアンドリサーチ	Microcarrier for stem cell culture
AU2009267137A1 (en) *	2008-06-30	2010-01-07	Centocor Ortho Biotech Inc.	Differentiation of pluripotent stem cells
US8008075B2 (en) *	2008-11-04	2011-08-30	Viacyte, Inc.	Stem cell aggregate suspension compositions and methods of differentiation thereof
CA2770753C (en) *	2009-08-12	2019-01-15	Kyoto University	Method for inducing differentiation of pluripotent stem cells into neural precursor cells
JP5936134B2 (en) *	2010-06-15	2016-06-15	国立大学法人京都大学	Selection method of human induced pluripotent stem cells
KR101836850B1 (en) *	2010-08-31	2018-03-09	얀센 바이오테크 인코포레이티드	Differentiation of human embryonic stem cells
MY177150A (en) *	2011-02-28	2020-09-08	Stempeutics Res Malaysia Sdn Bhd	Isolation and expansion of adult stem cells, their therapeutic composition and uses thereof
WO2013056072A1 (en) *	2011-10-13	2013-04-18	Wisconsin Alumni Research Foundation	Generation of cardiomyocytes from human pluripotent stem cells
AU2012355698B2 (en) *	2011-12-22	2018-11-29	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells into single hormonal insulin positive cells
US10519422B2 (en) *	2012-02-29	2019-12-31	Riken	Method of producing human retinal pigment epithelial cells

2014
- 2014-05-21 MX MX2016005657A patent/MX2016005657A/en unknown
- 2014-05-21 KR KR1020167014409A patent/KR20160079072A/en not_active Ceased
- 2014-05-21 WO PCT/US2014/038993 patent/WO2015065524A2/en not_active Ceased
- 2014-05-21 CN CN201480059910.5A patent/CN105793413A/en active Pending
- 2014-05-21 KR KR1020187034291A patent/KR20180128529A/en not_active Abandoned
- 2014-05-21 JP JP2016527338A patent/JP2016534731A/en active Pending
- 2014-05-21 AU AU2014342995A patent/AU2014342995C1/en not_active Ceased
- 2014-05-21 EP EP14857034.4A patent/EP3063268A4/en not_active Withdrawn
- 2014-05-21 SG SG11201603045VA patent/SG11201603045VA/en unknown
- 2014-05-21 RU RU2016121409A patent/RU2689710C2/en active
- 2014-05-21 CA CA2928639A patent/CA2928639A1/en not_active Abandoned
- 2014-06-17 JP JP2016527450A patent/JP2017500013A/en active Pending
- 2014-06-17 BR BR112016009393A patent/BR112016009393A8/en not_active Application Discontinuation
- 2014-06-17 KR KR1020187034483A patent/KR20180130001A/en not_active Withdrawn
- 2014-06-17 CA CA2928741A patent/CA2928741A1/en not_active Abandoned
- 2014-06-17 EP EP14859059.9A patent/EP3063269A4/en not_active Withdrawn
- 2014-06-17 RU RU2016121404A patent/RU2016121404A/en not_active Application Discontinuation
- 2014-06-17 WO PCT/US2014/042796 patent/WO2015065537A1/en not_active Ceased
- 2014-06-17 SG SG11201603047PA patent/SG11201603047PA/en unknown
- 2014-06-17 KR KR1020167014406A patent/KR20160079071A/en not_active Abandoned
- 2014-06-17 MX MX2016005658A patent/MX2016005658A/en unknown
- 2014-06-17 AU AU2014343007A patent/AU2014343007C1/en not_active Ceased
- 2014-06-17 CN CN201480059902.0A patent/CN105683362A/en active Pending
2016
- 2016-04-27 PH PH12016500783A patent/PH12016500783A1/en unknown
- 2016-04-27 PH PH12016500782A patent/PH12016500782A1/en unknown
2018
- 2018-07-26 AU AU2018208717A patent/AU2018208717A1/en not_active Abandoned
- 2018-07-26 AU AU2018208707A patent/AU2018208707A1/en not_active Abandoned

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014106141A1 (en) *	2012-12-31	2014-07-03	Janssen Biotech, Inc.	Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
WO2015065524A2 (en) *	2013-11-01	2015-05-07	Janssen Biotech, Inc.	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015065537A1 *

Also Published As

Publication number	Publication date
AU2018208717A1 (en)	2018-08-16
BR112016009393A8 (en)	2020-03-24
MX2016005657A (en)	2017-01-05
AU2014343007A1 (en)	2016-05-05
RU2016121409A (en)	2017-12-04
WO2015065524A2 (en)	2015-05-07
RU2016121404A3 (en)	2018-03-29
RU2016121404A (en)	2017-12-04
EP3063268A4 (en)	2017-11-29
AU2014342995C1 (en)	2018-08-09
AU2014343007B2 (en)	2018-04-26
PH12016500782A1 (en)	2016-06-13
WO2015065524A3 (en)	2015-08-13
WO2015065537A1 (en)	2015-05-07
CA2928741A1 (en)	2015-05-07
RU2689710C2 (en)	2019-05-29
CN105683362A (en)	2016-06-15
KR20160079072A (en)	2016-07-05
JP2016534731A (en)	2016-11-10
CA2928639A1 (en)	2015-05-07
PH12016500783A1 (en)	2016-06-13
AU2014342995B2 (en)	2018-04-26
AU2014342995A1 (en)	2016-05-05
KR20160079071A (en)	2016-07-05
SG11201603047PA (en)	2016-05-30
EP3063268A2 (en)	2016-09-07
JP2017500013A (en)	2017-01-05
KR20180130001A (en)	2018-12-05
SG11201603045VA (en)	2016-05-30
EP3063269A1 (en)	2016-09-07
AU2018208707A1 (en)	2018-08-16
KR20180128529A (en)	2018-12-03
CN105793413A (en)	2016-07-20
AU2014343007C1 (en)	2018-08-09
MX2016005658A (en)	2017-01-05
RU2016121409A3 (en)	2018-03-29

Publication	Publication Date	Title
EP3063269A4 (en)	2017-07-12	Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells
EP2938722A4 (en)	2017-03-22	Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
IL283094A (en)	2021-06-30	In vitro differentiation of pluripotent stem cells into pancreatic endoderm and endocrine cells
ZA201802252B (en)	2020-01-29	Differentiation of human embryonic stem cells into pancreatic endocrine cells
IL241286A0 (en)	2015-11-30	Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
ZA201500224B (en)	2017-09-27	Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201505112SA (en)	2015-07-30	Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
SG11201505128SA (en)	2015-07-30	Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
EP3334820A4 (en)	2019-01-02	Induced extended pluripotent stem cells, methods of making and using
EP3047017A4 (en)	2017-10-11	Methods of mammalian retinal stem cell production and applications
EP2970894A4 (en)	2017-01-04	Stem cell culture media and methods of enhancing cell survival
IL241930B (en)	2020-06-30	Isolated naive pluripotent stem cells and methods of generating same
EP2904103B8 (en)	2020-03-11	Method for preparing induced pluripotent stem cells and its applications
ZA201407241B (en)	2016-05-25	Defined media for expansion and maintenance of pluripotent stem cells
EP3234109A4 (en)	2018-06-27	Suspension culturing of pluripotent stem cells
EP3198004A4 (en)	2018-02-28	TGFß SIGNALING INDEPENDENT NAÏVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE
IL235132A0 (en)	2014-12-31	Differentiation n of human embryonic stem cells into pancreatic endoderm
IL243634A0 (en)	2016-03-31	Method and culture medium for in vitro culturing of stem cells
EP3043805A4 (en)	2017-05-31	Biologic prosthesis and methods of production and use
EP3088415A4 (en)	2017-06-14	Method for inducing differentiation of pluripotent stem cells into endodermal cells
EP3008174A4 (en)	2017-03-08	Method of efficiently establishing induced pluripotent stem cells
EP3045451A4 (en)	2017-03-08	Compound promoting differentiation of pluripotent stem cells into cardiomyocytes
EP3045531A4 (en)	2017-04-19	Method for inducing differentiation of induced pluripotent stem cells and method for selecting induced pluripotent stem cells
TH1601002462A (en)	2017-10-05	Suspension and clustering of human pluripotent stem cells for growth and transformation into endocrine cells of the pancreas
TH1601002463A (en)	2018-06-21	Suspension and clustering of human pluripotent stem cells for growth and transformation into endocrine cells of the pancreas

Legal Events

Date	Code	Title	Description
2016-08-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2016-09-07	17P	Request for examination filed	Effective date: 20160601
2016-09-07	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-09-07	AX	Request for extension of the european patent	Extension state: BA ME
2017-02-08	DAX	Request for extension of the european patent (deleted)
2017-07-12	A4	Supplementary search report drawn up and despatched	Effective date: 20170613
2017-07-12	RIC1	Information provided on ipc code assigned before grant	Ipc: C07D 403/00 20060101ALI20170607BHEP Ipc: C12N 5/0735 20100101ALI20170607BHEP Ipc: A61K 31/41 20060101ALI20170607BHEP Ipc: C12N 5/079 20100101ALI20170607BHEP Ipc: C12N 5/02 20060101ALI20170607BHEP Ipc: C12N 5/071 20100101AFI20170607BHEP Ipc: C12N 5/077 20100101ALI20170607BHEP
2018-07-04	17Q	First examination report despatched	Effective date: 20180604
2020-06-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2020-07-29	18D	Application deemed to be withdrawn	Effective date: 20200103